hemoglobin analysis News
-
Updated results from clinical trial with Diamyd presented today at diabetes conference
Updated 12-month results from the open-label investigator-initated Phase II clinical trial GADinLADA that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd® in individuals diagnosed with Latent Autoimmune Diabetes in Adults (LADA) were presented today at the European Association for the Study of Diabetes (EASD) conference in Stockholm, Sweden. The updated ...
-
Daxor Corporation Presents New Data Validating the Benefit of the BVA-100 Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 blood test in identifying heart failure patient-specific phenotypes and detecting true anemia. These data from two separate studies were presented at the American Heart Association (AHA) Scientific Sessions virtual meeting from ...
-
Nova Blood Gas Analyzers Add Important New Test: Mean Corpuscular Hemoglobin Concentration (MCHC)
Waltham, MA - Nova Biomedical announces the addition of another important critical care parameter to its Stat Profile Prime Plus blood gas analyzer—the ability to rapidly calculate and report mean corpuscular hemoglobin concentration (MCHC). MCHC is a measure of the hemoglobin concentration in a given volume of packed red blood cells. MCHC, along with measured hemoglobin and ...
-
Frost & Sullivan Lauds Epinex Diagnostics` Monthly G1A Test as a Superior Alternative to the Existing Diabetes Management Paradigm
Based on its recent analysis of the diabetes point-of-care (POC) diagnostics market, Frost & Sullivan recognizes Epinex Diagnostics with the 2014 Global Frost & Sullivan Award for New Product Innovation. The company's G1A™ rapid test for glycated albumin has initially the potential to bridge the gap between daily self-monitored blood glucose (SMBG) and quarterly glycated hemoglobin ...
-
Gauss Surgical Announces FDA 510(k) Clearance of Triton Canister App for Accurate Surgical Blood Loss Monitoring
Gauss Surgical today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Triton Canister App, the second core product in its Triton System™ portfolio, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. Now, in addition to estimating blood loss on surgical sponges, the system can accurately ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you